Safety of Lumiracoxib in Patients With Osteoarthritis
Status:
Completed
Trial end date:
2001-03-01
Target enrollment:
Participant gender:
Summary
This safety study evaluated the incidence of gastrointestinal adverse events and edema in
patients with osteoarthritis treated with lumiracoxib and rofecoxib as comparator